Report Company Directory

Pharma Foods International

• Biotech Monthly: November 2018 by Mizuho Securities
• バイオマンスリー (2018å¹´11月号) by Mizuho Securities
• バイオマンスリー (2018å¹´10月号) by Mizuho Securities
• Biotech Monthly: October 2018 by Mizuho Securities
• Ford Equity International Rating and Forecast Report by Ford Equity Research

Pharma Mar SA

• Pharma Mar SA: 1 director by SmartInsider
• ValuEngine Rating and Forecast Report for PHMMF by ValuEngine Inc
• ValuEngine Rating and Forecast Report for PHMMF by ValuEngine Inc
• ValuEngine Rating and Forecast Report for PHMMF by ValuEngine Inc
• ValuEngine Rating and Forecast Report for PHMMF by ValuEngine Inc
• For PHARMA MAR SA, the environment deterioration entails a downgrade to Neutral by TheScreener
• PharmaMar - Zepsyre misses in Ovarian, SCLC still promising by Edison Investment Research
• PharmaMar - Aplidin and Zepsyre milestones coming up by Edison Investment Research
• A mixed set of results in 1H17 by Bankinter S.A.
• Preparing for ovarian Phase III data by Edison Investment Research

Pharma Mar SA

• Santander European Weekly Wrap, Friday, February 6, 2026 by Santander
• SANTANDER IBERIAN SMALL & MID CAPS, February 5, 2026♨ by Santander
• SANTANDER IBERIAN SMALL & MID CAPS, February 4, 2026♨ by Santander
• SANTANDER IBERIAN SMALL & MID CAPS, February 3, 2026♨ by Santander
• SANTANDER IBERIAN SMALL & MID CAPS, February 2, 2026♨ by Santander
• SANTANDER EUROPE February 2, 2026 ♨ by Santander
• SANTANDER IBERIAN SMALL & MID CAPS, January 30, 2026♨ by Santander
• Pharma Mar by Santander
• ODDO BHF SECURITIES Small & MIDCAP MORNING NEWS – 01/29/2026 by Oddo BHF
• ODDO BHF SECURITIES Small & MIDCAP MORNING NEWS – 29/01/2026 by Oddo BHF

PHARMABCINE INC

PharmaBlock Sciences (Nanjing) (A)

• Vermilion Int'l Compass: Global Equity Strategy by Vermilion Research